Teknova Announces $15.4 Million Private Placement
eknova currently intends to use the net proceeds from the private placement for general corporate purposes.
July 12, 2024
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
eknova currently intends to use the net proceeds from the private placement for general corporate purposes.
VenoStent builds on Momentum with New $3.6 Million NIH SBIR Grant to fund U.S. clinical trial of breakthrough medical device showing promise in improving dialysis patient outcomes.
Prashant Warier, Co-founder and CEO of Qure.ai, “This strategic investment in Qure.ai from the Merck Global Health Innovation Fund will enable us to expedite our work in foundation models and expand the reach of our AI both geographically and demographically.”